Odimo INC
CIK:0001292026|SEC Filings
|
Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified |
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2012
|
Dec. 31, 2011
|
|
| Statements of Operations [Abstract] | ||
| Revenues | ||
| Operating expenses | 112 | 90 |
| Total operating expenses | 112 | 90 |
| Loss from Operations | (112) | (90) |
| Other Income (Expense): | ||
| Other income (expense) | (3) | |
| Gain on debt forgiveness | 230 | |
| Net Income (Loss) | $ (115) | $ 140 |
| Net Income (Loss) per Common Share | ||
| Basic and diluted | $ (0.01) | $ 0.01 |
| Weighted Average Number of Shares: | ||
| Basic and diluted | 11,086 | 11,086 |
|
Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified |
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2012
|
Dec. 31, 2011
|
|
| Cash Flows from Operating Activities: | ||
| Net (Loss) Income | $ (115) | $ 140 |
| Adjustments to reconcile (net loss) income to net cash used in operating activities: | ||
| Charge in lieu of compensation contributed by officer and related party | 56 | 56 |
| Gain on forgiveness of debt | (230) | |
| Increase (decrease) in: | ||
| Accrued liabilities | 5 | 10 |
| Net cash used in operating activities | (54) | (24) |
| Cash Flows from Investing Activities: | ||
| Net cash provided by investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from notes payable to related party | 50 | 30 |
| Net cash provided by financing activities | 50 | 30 |
| Net Increase (decrease) in Cash and Cash Equivalents | (4) | 6 |
| Cash and Cash Equivalents, Beginning | 9 | 3 |
| Cash and Cash Equivalents, Ending | 5 | 9 |
| Cash paid during the period for: | ||
| Interest | ||
| Taxes | ||
|
Balance Sheets (USD $)
In Thousands, unless otherwise specified |
Dec. 31, 2012
|
Dec. 31, 2011
|
|---|---|---|
| Current Assets: | ||
| Cash | $ 5 | $ 9 |
| Total Assets | 5 | 9 |
| Current Liabilities: | ||
| Accrued liabilities | 25 | 20 |
| Notes payable, related party | 83 | 33 |
| Total current liabilities | 108 | 53 |
| Stockholders' Deficiency: | ||
| Preferred stock, $0.001 par value, 50 million shares authorized, none issued and outstanding | ||
| Common stock, $0.001 par value, 300 million shares authorized, 11,086 shares issued and outstanding | 10 | 10 |
| Additional paid-in capital | 104,695 | 104,639 |
| Accumulated deficit | (104,808) | (104,693) |
| Total stockholders' deficiency | (103) | (44) |
| Total liabilities and stockholders' deficiency | $ 5 | $ 9 |